Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science, from a molecular point of view. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer. Topics of interest include, but are not limited to: cell and tumor biology, angiogenesis, animal models, metastasis, cancer antigens and the immune response to them, cellular signalling and molecular biology, epidemiology, genetic and molecular profiling of cancer and molecular targets, cancer stem cells, DNA damage and repair, cell cycle, apoptosis, molecular virology and vaccine- and antibody-based cancer therapies.

Molecular Cancer provides an important forum for exciting findings in cancer-related research, presenting an unparalleled opportunity to communicate information to specialists and the public. The online appearance of Molecular Cancer allows the immediate publication of accepted articles and the presentation of large amounts of data and supplemental information to ensure that new research is disseminated as efficiently and quickly as possible to the scientific community.

Research
Letters to the Editor
Reviews

Editors-in-Chief
Christophe Nicot, Kansas University Medical Center, USA 

Associate Editors
Helen Abud, Monash University, Australia 
Suresh V. Ambudkar, National Cancer Institute, USA
Suresh Alahari, Louisiana State University School of Medicine, USA 
Prof Surinder Batra, University of Nebraska Medical Center, USA 
George Calin, MD Anderson Cancer Center, USA
Amancio Carnero, Instituto de Biomedicina de Sevilla, Spain
Srikumar Chellappan, Moffitt Cancer Center and Research Institute, USA
Zhong Chen, National Institutes of Health, USA  
Liang Cheng, Indiana University Medical Center, USA 
William B. Coleman, University of North Carolina School of Medicine - Chapel Hill, USA
Federica Di Nicolantonio, Candiolo Cancer Institute, Italy
Jia Fang, Moffitt Cancer Center & Research Institute, USA
Haiyong Han, Translational Genomics Research Institute, USA 
Frank Jones, Tulane University, USA
Wei Kang, Chinese University of Hong Kong, China
Richard K Kefford, Macquarie University, Australia
Lukas Kenner, Medical University of Vienna, Austria
Sung-Hoon Kim, Kyung Hee University, South Korea
Gopal Kundu, National Center for Cell Science, India 
Sam W. Lee, Massachusetts General Hospital Cutaneous Biology Research, USA
Steven Libutti, Montefiore Medical Center, USA 
Jaroslaw Maciejewski, Cleveland Ohio Clinic, USA
Alberto M Martelli, University of Bologna, Italy
Giovanni Melillo, National Cancer Institute, USA
Ian Mills, Queen's University Belfast, UK  
Lucio Miele, Scott Cancer Center and Louisiana Cancer Research, USA
Jingxuan Pan, Sun Yat-sen University, China 
Jesus M Paramio, Molecular Oncology Unit, CIEMAT, Spain 
Yong Peng, West China Hospital, Sichuan University, China
Johannes Schmid, Medical University of Vienna, Austria 
Yongfeng Shang, Peking University Health Science Center, China 
Keshav K Singh, UAB Comprehensive Cancer Center, USA 
Shi-Yong Sun, Emory University, USA
Francois Vallette, Université de Nantes, France
Gyorgy Vereb, University of Debrecen, Hungary 
Elizabeth Vincan, University of Melbourne, Australia
Zefeng Wang, University of North Carolina - Chapel Hill, USA
Kishore Wary, University of Illinois at Chicago, USA
Haim Werner, Tel Aviv University, Israel  
Go J Yoshida, Juntendo University, Japan
Wei Zhang, The University of Texas, USA
Shengtao Zhou, West China Second Hospital, Sichuan University, China